Bonumose has filed a notice of an exempt offering of securities to raise $51,628,398.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Bonumose is raising $51,628,398.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ed Rogers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Bonumose
Bonumose is an early-stage food ingredient manufacturer specializing in the affordable production of delicious, good-for-you sugars such as tagatose and allulose. Built on innovative, enzymatic technology discovered by Dr. Daniel Wichelecki, Bonumose developed a novel platform to produce naturally-occurring ingredients in commercial-scale quantities that would not otherwise be cost-effective or sustainable. Our mission is to offer healthy ingredients that can be used to meet consumers demands for delicious products that do not burden the waistband or the wallet. Good-for-you sugars are naturally-occurring just like glucose, fructose and sucrose, but are called rare sugars because they are much less abundant in nature. Despite this scarcity, rare sugars are packed with health benefits, promoting healthy teeth, glycemic control and improved gut health. They are just as versatile as more commonly-consumed sugars such as sucrose, sharing a similar taste and technical profile that facilitates their easy incorporation into a variety of food and beverage products.
To learn more about Bonumose, visit http://www.bonumose.com/
Contact:
Ed Rogers, Chief Executive Officer
276-206-7337
https://www.linkedin.com/in/edwinorogers/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.